Mackenzie Financial Corp Sells 2,059 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Mackenzie Financial Corp trimmed its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 10.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,766 shares of the company’s stock after selling 2,059 shares during the period. Mackenzie Financial Corp’s holdings in Pediatrix Medical Group were worth $165,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Pacer Advisors Inc. boosted its holdings in shares of Pediatrix Medical Group by 126.9% in the 4th quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock worth $30,092,000 after acquiring an additional 1,809,828 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Pediatrix Medical Group by 4.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,485,465 shares of the company’s stock worth $18,880,000 after purchasing an additional 57,193 shares during the last quarter. Invesco Ltd. increased its stake in shares of Pediatrix Medical Group by 2.5% in the third quarter. Invesco Ltd. now owns 705,240 shares of the company’s stock valued at $8,964,000 after buying an additional 16,875 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of Pediatrix Medical Group by 43.7% in the third quarter. AQR Capital Management LLC now owns 559,879 shares of the company’s stock valued at $7,116,000 after buying an additional 170,375 shares during the last quarter. Finally, Smith Graham & Co. Investment Advisors LP lifted its position in Pediatrix Medical Group by 51.5% during the 4th quarter. Smith Graham & Co. Investment Advisors LP now owns 534,621 shares of the company’s stock worth $4,972,000 after buying an additional 181,662 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Stock Down 0.2 %

Shares of NYSE MD opened at $9.02 on Tuesday. The firm has a 50 day moving average price of $9.20 and a 200 day moving average price of $9.56. The stock has a market cap of $757.95 million, a P/E ratio of -12.36, a P/E/G ratio of 2.44 and a beta of 1.58. Pediatrix Medical Group, Inc. has a 52-week low of $7.70 and a 52-week high of $15.06. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.24 and a current ratio of 1.24.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. The business had revenue of $496.44 million for the quarter, compared to analyst estimates of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. The firm’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.46 earnings per share. Analysts expect that Pediatrix Medical Group, Inc. will post 1.12 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have weighed in on MD. Mizuho lowered their price objective on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. TheStreet downgraded Pediatrix Medical Group from a “c” rating to a “d” rating in a report on Friday, February 23rd. Truist Financial dropped their target price on Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a research report on Wednesday, February 21st. Finally, Jefferies Financial Group cut their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, March 6th. Five equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $10.30.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.